Schrödinger

Schrödinger is a global leader in computational chemistry, molecular modeling, and physics-based software solutions for molecular discovery and design. Founded in 1990, Schrödinger has pioneered the development of advanced simulation software that accelerates research in the pharmaceutical, biotechnology, and materials science industries. The company’s platform leverages physics-based computational methods to enable scientists to discover, optimize, and design molecules with greater speed and accuracy than traditional experimental approaches.\n\nSchrödinger’s software is widely used by leading pharmaceutical and biotechnology companies to streamline drug discovery, reduce costs, and improve the probability of clinical success. The platform supports the entire drug discovery pipeline, from target identification and hit discovery to lead optimization and candidate selection. Schrödinger’s solutions are also integral to materials science research, enabling the design and optimization of new materials, polymers, catalysts, and electronic devices.\n\nKey products include Maestro (a comprehensive molecular modeling environment), LiveDesign (a collaborative platform for drug discovery teams), and a suite of tools for molecular dynamics, quantum mechanics, and cheminformatics. Schrödinger’s technology is used by academic institutions, government labs, and industry leaders worldwide.\n\nThe company is also actively involved in collaborative drug discovery programs, advancing a pipeline of therapeutics built from its platform. Schrödinger’s therapeutics group focuses on high-value targets with strong genetic or clinical validation, aiming to deliver innovative treatments for unmet medical needs.\n\nIndustries served include pharmaceuticals, biotechnology, materials science, chemicals, and academia. Notable clients and partners include many of the world’s top pharmaceutical companies, as well as research universities and government agencies.\n\nSchrödinger is headquartered in New York, NY, with offices and collaborators around the globe. The company is publicly traded on the NASDAQ (SDGR) and continues to invest in scientific research, talent, and technology to drive innovation in molecular discovery.\n\nFor more information, visit https://www.schrodinger.com.

The Nombase Funding database has 4,288 records from over 1,788 companies.

There's no funding data for this company.